Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (9)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Bilous, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bilous, R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (1999) 14: 2562-2564
© 1999 European Renal Association-European Dialysis and Transplant Association

Editorial Comments

Blood pressure control in type 2 diabetes—what does the United Kingdom prospective diabetes study (UKPDS) tell us?

Rudy Bilous

University of Newcastle upon Tyne and South Tees Acute Trust, Middlesbrough, UK

Correspondence and offprint requests to: Rudy Bilous MD, South Tees Acute Trust, Middlesbrough, TS4 3BW, UK.

Hypertension is a commonly associated condition with type 2 diabetes; depending on its definition, it is present in at least 25% of patients [1]. Using the current definition of 130/85 mmHg proposed by the Joint National Commission VI Report from the USA [2] then 85% of 1565 type 2 patients in our diabetic clinic in Middlesbrough would be classified as hypertensive. The publication of the Hypertension Optimum Treatment (HOT) [3] and Systolic Hypertension in Europe (Syst-Eur) [4] studies have demonstrated that lowering blood pressure reduces stroke rate in both non-diabetic and diabetic patients, with a significantly greater benefit in diabetes. There is continuing debate about which drug should be used, however.

The UK Prospective Diabetes Study . . . [Full Text of this Article]

References


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Diabetes CareHome page
C. A. Aguilar-Salinas, O. V. Monroy, F. J. Gomez-Perez, A. G. Chavez, A. L. Esqueda, V. M. Cuevas, J. A. Rull-Rodrigo, and R. T. Conyer
Characteristics of Patients With Type 2 Diabetes in Mexico: Results from a large population-based nationwide survey
Diabetes Care, July 1, 2003; 26(7): 2021 - 2026.
[Abstract] [Full Text] [PDF]